Skip to main content
. 2021 Aug 9;30(10):902–910. doi: 10.1097/IJG.0000000000001918

TABLE 4.

Multivariable Survival Analysis of Laser Trabeculoplasty Outcomes

Parameters Hazard Ratio 95% Hazard Ratio Confidence Limits P Comments
Age (y)
 18-39 1.37 1.22 1.53 <0.0001* Age: per patient eye, 5 levels: 18-39, 40-64, 65-79 (reference), 80+
 40-64 0.96 0.93 1.00 0.0738
 80+ 1.44 1.39 1.49 <0.0001*
 Unknown 1.60 1.33 1.93 <0.0001*
Sex
 Female 0.93 0.90 0.95 <0.0001* Sex: per patient, 3 levels: male (reference), female, unspecified
 Unspecified 1.19 0.93 1.48 0.1345
Region
 Midwest 0.92 0.89 0.95 <0.0001* Region: per patient eye, provider region, 5 levels: Midwest, Northeast, West, South (reference), unknown
 Northeast 0.91 0.88 0.95 <0.0001*
 West 0.94 0.90 0.98 0.0046*
 Unknown 1.22 1.05 1.42 0.0103*
Race
 Asian 1.15 1.04 1.28 0.0092* Race: per patient, 6 levels: White (reference), Asian, Black, Hispanic, multirace/other, unknown
 Black 1.10 1.05 1.15 <0.0001*
 Hispanic 0.91 0.85 0.98 0.0088*
 Multi/other 0.97 0.92 1.02 0.2722
 Unknown 1.54 1.46 1.62 <0.0001*
Insurance type
 Dual Medicare and Medicaid 0.72 0.68 0.76 <0.0001* Insurance: per patient, 8 levels: dual Medicare/Medicaid, Medicaid, Medicare advantage, Medicare fee-for-Service, military, other government, unknown, private (reference)
 Medicaid 1.01 0.92 1.11 0.8087
 Medicare advantage 0.82 0.77 0.86 <0.0001*
 Medicare FFS 0.77 0.74 0.80 <0.0001*
 Military 1.28 1.10 1.49 0.0016*
 Other Government 1.31 0.96 1.79 0.0864
 Unknown 1.13 1.07 1.19 <0.0001*
No. glaucoma medications 0.96 0.95 0.97 <0.0001*
Mean baseline IOP 1.01 1.01 1.01 <0.0001*
Mean baseline VA 1.18 1.13 1.24 <0.0001*
Provider status
 Group 2 1.10 1.05 1.14 <0.0001* Provider status: per patient eye, 3 levels: group 1 (glaucoma surgeon) (reference), group 2 (other anterior segment surgeon), or group 3 (unknown)
 Group 3 1.25 1.20 1.31 <0.0001*
 No provider information 0.72 0.60 0.88 0.001*
Prior glaucoma procedures
 Yes 1.03 0.92 1.14 0.6224
Prior lens surgery
 Yes 1.28 1.21 1.36 <0.0001*
Prior intravitreal injections
 Yes 1.05 0.96 1.16 0.2983
Diabetes
 Yes 1.07 1.03 1.11 0.0003*
Hypertension
 Yes 0.93 0.85 1.01 0.0765
Angle recession
 Yes 0.91 0.55 1.50 0.7104
Uveitis
 Yes 1.30 1.10 1.52 0.0009*
Provider LTP count in preceding year
 51-99 1.10 1.06 1.15 <0.0001* No. LTP performed by provider in the year preceding treatment date, per patient eye, 4 levels: <50 (reference), 50-99, 100-499, 500+
 100-499 1.21 1.17 1.25 <0.0001*
 500+ 1.24 1.14 1.34 <0.0001*
Glaucoma type
 Inflammation/drugs 1.62 1.30 2.01 <0.0001* Glaucoma type: per patient eye, 6 levels: suspect (reference), POAG, trauma, inflammation, other, unspecified
 POAG 1.71 1.64 1.79 <0.0001*
 Trauma/other eye disorders 1.59 1.32 1.93 <0.0001*
 Other glaucoma 1.10 0.80 1.50 0.5712
 Unspecified glaucoma 0.66 0.61 0.70 <0.0001*
Glaucoma severity
 Moderate 0.91 0.88 0.95 <0.0001* Glaucoma Severity: per patient eye, stage closest to LTP date, 6 levels: mild (reference), moderate, severe, indeterminate, unspecified/missing, not applicable
 Severe 0.89 0.85 0.94 <0.0001*
 Indeterminate 1.06 0.98 1.16 0.1557
 Missing/unspecified 0.37 0.35 0.39 <0.0001*
Lens status
 Aphakia 0.76 0.59 0.98 0.0339 Lens status: 4 levels: cataract (reference), pseudophakia, aphakia, unknown
 Pseudophakia 0.85 0.80 0.90 <0.0001*
 Unknown 0.57 0.55 0.59 <0.0001*
LTP treatment group
 Double 1.09 1.00 1.20 0.0589 LTP treatment in 1 session (reference) or in 2 or more session (double)

All P values are from a multivariable Cox proportional hazards regression.

*

Statistically significant.

FFS indicates fee-for-service; IOP, intraocular pressure; LTP, laser trabeculoplasty; POAG, primary open angle glaucoma; VA, visual acuity.